DSpace Repository

Exploring a Mitochondria Targeting, Dinuclear Cyclometalated Iridium (III) Complex for Image-Guided Photodynamic Therapy in Triple-Negative Breast Cancer Cells

Show simple item record

dc.contributor.author Neelambaran, N
dc.contributor.author Shamjith, S
dc.contributor.author Murali, V P
dc.contributor.author Maiti, K K
dc.contributor.author Joseph, J
dc.date.accessioned 2024-02-26T10:04:28Z
dc.date.available 2024-02-26T10:04:28Z
dc.date.issued 2023-12-07
dc.identifier.citation ACS Applied Bio Materials; 6(12):5776–5788 en_US
dc.identifier.uri https://pubs.acs.org/doi/10.1021/acsabm.3c00883
dc.identifier.uri http://localhost:8080/xmlui/handle/123456789/4722
dc.description.abstract Photodynamic therapy (PDT) has emerged as an efficient and noninvasive treatment approach utilizing laser-triggered photosensitizers for combating cancer. Within this rapidly advancing field, iridium-based photosensitizers with their dual functionality as both imaging probes and PDT agents exhibit a potential for precise and targeted therapeutic interventions. However, most reported classes of Ir(III)-based photosensitizers comprise mononuclear iridium(III), with very few examples of dinuclear systems. Exploring the full potential of iridium-based dinuclear systems for PDT applications remains a challenge. Herein, we report a dinuclear Ir(III) complex (IRDI) along with a structurally similar monomer complex (IRMO) having 2-(2,4-difluorophenyl)pyridine and 4′-methyl-2,2′-bipyridine ligands. The comparative investigation of the mononuclear and dinuclear Ir(III) complexes showed similar absorption profiles, but the dinuclear derivative IRDI exhibited a higher photoluminescence quantum yield (Φp) of 0.70 compared to that of IRMO (Φp = 0.47). Further, IRDI showed a higher singlet oxygen generation quantum yield (Φs) of 0.49 compared to IRMO (Φs = 0.28), signifying the enhanced potential of the dinuclear derivative for image-guided photodynamic therapy. In vitro assessments indicate that IRDI shows efficient cellular uptake and significant photocytotoxicity in the triple-negative breast cancer cell line MDA-MB-231. In addition, the presence of a dual positive charge on the dinuclear system facilitates the inherent mitochondria-targeting ability without the need for a specific targeting group. Subcellular singlet oxygen generation by IRDI was confirmed using Si-DMA, and light-activated cellular apoptosis via ROS-mediated PDT was verified through various live–dead assays performed in the presence and absence of the singlet oxygen scavenger NaN3. Further, the mechanism of cell death was elucidated by an annexin V-FITC/PI flow cytometric assay and by investigating the cytochrome c release from mitochondria using Western blot analysis. Thus, the dinuclear complex designed to enhance spin–orbit coupling with minimal excitonic coupling represents a promising strategy for efficient image-guided PDT using iridium complexes. en_US
dc.language.iso en en_US
dc.publisher American Chemical Society en_US
dc.subject dinuclear iridium complex en_US
dc.subject reactive oxygen species (ROS) en_US
dc.subject photosensitizers (PSs) en_US
dc.subject photodynamic therapy (PDT) en_US
dc.subject targeted therapy apoptosis en_US
dc.title Exploring a Mitochondria Targeting, Dinuclear Cyclometalated Iridium (III) Complex for Image-Guided Photodynamic Therapy in Triple-Negative Breast Cancer Cells en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

  • 2023
    Research articles authored by NIIST researchers published in 2023

Show simple item record

Search DSpace


Advanced Search

Browse

My Account